Triterpenoids, an important group of secondary metabolites, are widely distributed in nature. Many triterpenoids have been found with potential therapeutic effect against diabetes mellitus. However, the use of triterpenoids for the treatment of diabetes has not been systematically discussed previously. This review summarized the anti-diabetic activity of natural triterpenoids reported since the late 1980s with the emphasis on the molecular mechanisms.
American Diabetes Association. (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care, 33, (Supplement-1), S62–S67.
2.
SalimB. (2005) Diabetes mellitus and its treatment. International Journal of Diabetes and Metabolism, 13, 111–134.
3.
LiW.L., ZhengH.C., BukuruJ., De KimpeN. (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology, 92, 1–21.
4.
AlqahtaniA., HamidK., KamA., WongK.H., AbdelhakZ., Razmovski-NaumovskiV., ChanK., LiK.M., GroundwaterP.W., LiG.Q. (2013) The pentacyclic triterpenoids in herbal medicines and their pharmacological activities in diabetes and diabetic complications. Current Medicinal Chemistry, 20, 908–931.
5.
HarlevE., NevoE., MirskyN., OfirR. (2013) Antidiabetic attributes of desert and steppic plants: a review. Planta Medica, 79, 425–436.
6.
ChenJ., MangelinckxS., AdamsA., WangZ.T., LiW.L., De KimpeN., LiW.L. (2015) Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Natural Product Communications, 10, 187–200.
7.
DzubakP., HajduchM., VydraD., HustovaA., KvasnicaM., BiedermannD., MarkovaL., UrbanM., SarekJ. (2006) Pharmacological activities of natural triterpenoids and their therapeutic implications. Natural Product Reports, 23, 394–411.
8.
Bis hayeeA., AhmedS., BrankovN., PerloffM. (2011) Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Frontiers in Bioscience, 16, 980–996.
YokozawaT., KobayashiT., OuraH., KawashimaY. (1985) Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chemical & Pharmaceutical Bulletin, 33, 869–872.
11.
LeeW.K., KaoS.T., LiuI.M., ChengJ.T. (2006) Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats. Clinical and Experimental Pharmacology and Physiology, 33, 27–32.
12.
GongY.H., JiangJ.X., LiZ., ZhuL.H., ZhangZ.Z. (1991) Hypoglycemic effect of sanchinoside C1 in alloxan-diabetic mice. Yao Xue Xue Bao, 26, 81–85.
13.
ChoW.C., ChungW.S., LeeS.K., LeungA.W., ChengC.H., YueK.K. (2006) Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. European Journal of Pharmacology, 21, 173–179.
14.
NorbergA., HoaN.K., LiepinshE., Van PhanD., ThuanN.D., JörnvallH., SillardR., OstensonC.G. (2004) A novel insulin-releasing substance, phanoside, from the plant Gynostemma pentaphyllum. The Journal of Biological Chemistry, 279, 41361–41367.
15.
XuA., WangH., HooR.L., SweeneyG., VanhoutteP.M., WangY., WuD., ChuW., QinG., LamK.S. (2009) Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice. Endocrinology, 150, 625–633.
16.
YuJ., ZhangY., SunS., ShenJ., QiuJ., YinX., YinH., JiangS. (2006) Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Canadian Journal of Physiology and Pharmacology, 84, 579–587.
17.
TanM.J., YeJ.M., TurnerN., Hohnen-BehrensC., KeC.Q., TangC.P., ChenT., WeissH.C., GesingE.R., RowlandA., JamesD.E., YeY. (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chemistry & Biology, 15, 263–273.
18.
SugiharaY., NojimaH., MatsudaH., MurakamiT., YoshikawaM., KimuraI. (2000) Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice. Journal of Asian Natural Products Research, 2, 321–327.
19.
KakoM., MiuraT., NishiyamaY., IchimaruM., MoriyasuM., KatoA. (1997) Hypoglycemic activity of some triterpenoid glycosides. Journal of Natural Products, 60, 604–605.
20.
ChoiJ., ShinM.H., ParkK.Y., LeeK.T., JungH.J., LeeM.S., ParkH.J. (2004) Effect of kaikasaponin III obtained from Pueraria thunbergiana flowers on serum and hepatic lipid peroxides and tissue factor activity in the streptozotocin-induced diabetic rat. Journal of Medicinal Food, 7, 31–37.
21.
MannaP., SinhaM., SilP.C. (2009) Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology, 257, 3–63.
22.
MatsudaH., LiY., MurakamiT., MatsumuraN., YamaharaJ., YoshikawaM. (1998) Antidiabetic principles of natural medicines. III. Structure-related inhibitory activity and action mode of oleanolic acid glycosides on hypoglycemic activity. Chemical & Pharmaceutical Bulletin, 46, 1399–1403.
23.
MatsudaH., MurakamiT., ShimadaH., MatsumuraN., YoshikawaM., YamaharaJ. (1997) Inhibitory mechanisms of oleanolic acid 3-O-monodesmosides on glucose absorption in rats. Biological & Pharmaceutical Bulletin, 20, 717–719.
24.
KalaiarasiP., PugalendiK.V. (2009) Antihyperglycemic effect of 18 beta-glycyrrhetinic acid, aglycone of glycyrrhizin, on streptozotocin-diabetic rats. European Journal of Pharmacology, 606, 269–273.
25.
HsuJ.H., WuY.C., LiuI.M., ChengJ.T. (2006) Release of acetylcholine to raise insulin secretion in Wistar rats by oleanolic acid, one of the active principles contained in Cornus officinalis. Neuroscience Letters, 404, 112–116.
26.
De TommasiN., De SimoneF., CirinoG., CicalaC., PizzaC. (1991) Hypoglycemic effects of sesquiterpene glycosides and polyhydroxylated triterpenoids of Eriobotrya japonica. Planta Medica, 57, 414–416.
27.
YoshikawaM., MatsudaH., HaradaE., MurakamiT., WariishiN., YamaharaJ., MurakamiN. (1994) Elatoside E, a new hypoglycemic principle from the root cortex of Aralia elata Seem.: Structure-related hypoglycemic activity of oleanolic acid glycosides. Chemical & Pharmaceutical Bulletin, 42, 1354–13561.
28.
YoshikawaM., MurakamiT., HaradaE., MurakamiN., YamaharaJ., MatsudaH. (1996) Bioactive saponins and glycosides. VII. On the hypoglycemic principles from the root cortex of Aralia elata Seem.: Structure-related hypoglycemic activity of oleanolic acid oligoglycoside. Chemical & Pharmaceutical Bulletin, 44, 1923–1927.
29.
YoshikawaM., HaradaE., MurakamiT., MatsudaH., WariishiN., YamaharaJ., MurakamiN., KitagawaI. (1994) Escins-Ia, Ib, IIa, IIb, and IIIa, bioactive triterpene oligoglycosides from the seeds of Aesculus hippocastanum L.: their inhibitory effects on ethanol absorption and hypoglycemic activity on glucose tolerance test. Chemical & Pharmaceutical Bulletin, 42, 1357–1359.
30.
IvorraM.D., PayaM., VillarA. (1988) Hypoglycemic and insulin release effects of tormentic acid: a new hypoglycemic natural product. Planta Medica, 54, 282–285.
31.
JayaprakasamB., OlsonL.K., SchutzkiR.E., TaiM.H., NairM.G. (2006) Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). Journal of Agricultural and Food Chemistry, 54, 243–248.
32.
TakagiS., MiuraT., IshibashiC., KawataT., IshiharaE., GuY., IshidaT. (2008) Effect of corosolic acid on the hydrolysis of disaccharides. Journal of Nutritional Science and Vitaminology, 54, 266–268.
33.
ChenJ., LiW.L., WuJ.L., RenB.R., ZhangH.Q. (2008) Euscaphic acid, a new hypoglycemic natural product from Folium Eriobotryae. Die Pharmazie, 63, 765–767.
34.
Tabatabaei-MalazyO., LarijaniB., AbdollahiM. (2012) A systematic review of in vitro studies conducted on effect of herbal products on secretion of insulin from Langerhans islets. Journal of Pharmaceutical Sciences, 15, 447–466.
35.
BansalP., WangQ. (2008) Insulin as a physiological modulator of glucagon secretion. American Journal of Physiology-Endocrinology and Metabolism, 295, E751–761.
ZhangY., JayaprakasamB., SeeramN.P., OlsonL.K., DeWittD., NairM.G. (2004) Insulin secretion and cyclooxygenase enzyme inhibition by cabernet sauvignon grape skin compounds. Journal of Agricultural and Food Chemistry, 52, 228–233.
38.
GilonP., HenquinJ.C. (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocrine Reviews, 22, 565–604.
39.
KosterJ.C., PermuttM.A., NicholsC.G. (2005) Diabetes and insulin secretion: the ATP-sensitive k+ channel (k ATP) connection. Diabetes, 54, 3065–3072.
40.
ReavenG.M. (1993) Role of insulin resistance in human disease (syndrome X): an expanded definition. Annual Review of Medicine, 44, 121–131.
41.
LeeW.K., KaoS.T., LiuI.M., ChengJ.T. (2007) Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Hormone and Metabolic Research, 39, 347–354.
42.
Le RoithD., ZickY. (2001) Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care, 24, 588–597.
43.
ChoiK., KimY.B. (2010) Molecular mechanism of insulin resistance in obesity and type 2 diabetes. The Korean Journal of Internal Medicine, 25, 119–129.
44.
ShangW., YangY., ZhouL., JiangB., JinH., ChenM. (2008) Ginsenoside Rb1 stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes. Journal of Endocrinology, 198, 561–569.
45.
ShangW., YangY., JiangB., JinH., ZhouL., LiuS., ChenM. (2007) Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPARgamma2 and C/EBP alpha gene expression. Life Sciences, 80, 618–625.
46.
JungS.H., HaY.J., ShimE.K., ChoiS.Y., JinJ.L., Yun-ChoiH.S., LeeJ.R. (2007) Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator. Biochemical Journal, 403, 243–250.
47.
ShiL., ZhangW., ZhouY.Y., ZhangY.N., LiJ.Y., HuL.H., LiJ. (2008) Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. European Journal of Pharmacology, 584, 21–29.
48.
TharejaS., AggarwalS., BhardwajT.R., KumarM. (2012) Protein tyrosine phosphatase 1B inhibitors: a molecular level legitimate approach for the management of diabetes mellitus. Medicinal Research Reviews, 32, 459–517.
49.
NaM., YangS., HeL., OhH., KimB.S., OhW.K., KimB.Y., AhnJ.S. (2006) Inhibition of protein tyrosine phosphatase 1B by ursane-type triterpenes isolated from Symplocos paniculata. Planta Medica, 72, 261–263.
50.
Ramírez-EspinosaJ.J., RiosM.Y., López-MartínezS., López-VallejoF., Medina-FrancoJ.L., PaoliP., CamiciG., Navarrete-VázquezG., Ortiz-AndradeR., Estrada-SotoS. (2011) Antidiabetic activity of some pentacyclic acid triterpenoids, role of PTP-1B: in vitro, in silico, and in vivo approaches. European Journal of Medicinal Chemistry, 46, 2243–2251.
51.
ThuongP.T., LeeC.H., DaoT.T., NguyenP.H., KimW.G., LeeS.J., OhW.K. (2008) Triterpenoids from the leaves of Diospyros kaki (persimmon) and their inhibitory effects on protein tyrosine phosphatase 1B. Journal of Natural Products, 10, 1775–1778.
52.
NaM., ThuongP.T., HwangI.H., BaeK., KimB.Y., OsadaH., AhnJ.S. (2010) Protein tyrosine phosphatase 1B inhibitory activity of 24-norursane triterpenes isolated from Weigela subsessilis. Phytotherapy Research, 24, 1716–1719.
53.
KwonJ.H., ChangM.J., SeoH.W., LeeJ.H., MinB.S., NaM., KimJ.C., WooM.H., ChoiJ.S., LeeH.K., BaeK. (2008) Triterpenoids and a sterol from the stem-bark of Styrax japonica and their protein tyrosine phosphatase 1B inhibitory activities. Phytotherapy Research, 22, 1303–1306.
54.
NaM., CuiL., MinB.S., BaeK., YooJ.K., KimB.Y., OhW.K., AhnJ.S. (2006) Protein tyrosine phosphatase 1B inhibitory activity of triterpenes isolated from Astilbe koreana. Bioorganic & Medicinal Chemistry Letters, 16, 3273–3276.
55.
ChoiY.H., ZhouW., OhJ., ChoeS., KimD.W., LeeS.H., NaM. (2012) Rhododendric acid A, a new ursane-type PTP1B inhibitor from the endangered plant Rhododendron brachycarpum G. Don. Bioorganic & Medicinal Chemistry Letters, 22, 6116–6119.
56.
NaM., KimB.Y., OsadaH., AhnJ.S. (2009) Inhibition of protein tyrosine phosphatase 1B by lupeol and lupenone isolated from Sorbus commixta. Journal of Enzyme Inhibition and Medicinal Chemistry, 24, 1056–1059.
57.
ChoiJ.Y., NaM., Hyun HwangI., Ho LeeS., Young BaeE., Yeon KimB., Seog AhnJ. (2009) Isolation of betulinic acid, its methyl ester and guaiane sesquiterpenoids with protein tyrosine phosphatase 1B inhibitory activity from the roots of Saussurea lappa C. B. Clarke. Molecules, 14, 266–272.
58.
HeilbronnL.K., SmithS.R., RavussinE. (2003) The insulin-sensitizing role of the fat derived hormone adiponectin. Current Pharmaceutical Design, 9, 1411–1418.
59.
WinderW.W., HardieD.G. (1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. American Journal of Physiology, 277, E1–10.
60.
Ha doT., TuanD.T., ThuN.B., NhiemN.X., NgocT.M., YimN., BaeK. (2009) Palbinone and triterpenes from Moutan Cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells. Bioorganic & Medicinal Chemistry Letters, 19, 5556–5559.
BermúdezV., FinolF., ParraN., ParraM., PérezA., PeñarandaL., VílchezD., RojasJ., ArráizN., VelascoM. (2010) PPAR-gamma agonists and their role in type 2 diabetes mellitus management. American Journal of Therapeutics, 17, 274–283.
MensinkM., BlaakE.E., van BaakM.A., WagenmakersA.J., SarisW.H. (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes, 50, 2548–2554.
65.
JiangB., YangY., JinH., ShangW., ZhouL., QianL., ChenM. (2008) Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFalpha in 3T3-L1 adipocytes. Phytotherapy Research, 22, 1434–1439.
66.
ClineG.W., JohnsonK., RegittnigW., PerretP., TozzoE., XiaoL., DamicoC., ShulmanG.I. (2002) Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes, 51, 2903–2910.
67.
PralyJ.P., VidalS. (2010) Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site. Mini-Reviews in Medicinal Chemistry, 10, 1102–1126.
68.
LeeJ., LeeH.I., SeoK.I., ChoH.W., KimM.J., ParkE.M., LeeM.K. (2014) Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice. Indian Journal of Experimental Biology, 52, 683–691.
69.
LuoJ.G., LiuJ., KongL.Y. (2008) New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors. Chemistry & Biodiversity, 5, 751–757.
70.
GuanT., LiY., SunH., TangX., QianY. (2009) Effects of maslinic acid, a natural triterpene, on glycogen metabolism in cultured cortical astrocytes. Planta Medica, 75, 1141–1143.
71.
MosaR.A., CeleN.D., MabhidaS.E., ShabalalaS.C., PendukaD., OpokuA.R. (2015) In vivo antihyperglycemic activity of a lanosteryl triterpene from Protorhus longifolia. Molecules, 20, 13374–13383.
72.
Van de LaarF.A. (2008) Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vascular Health and Risk Management, 4, 1189–1195.
73.
TundisR., LoizzoM.R., MenichiniF. (2010) Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini-Reviews in Medicinal Chemistry, 10, 315–331.
74.
TakagiS., MiuraT., IshibashiC., KawataT., IshiharaE., GuY., IshidaT. (2008) Effect of corosolic acid on the hydrolysis of disaccharides. Journal of Nutritional Science and Vitaminology, 54, 266–268.
75.
AliH., HoughtonP.J., SoumyanathA. (2006) alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. Journal of Ethnopharmacology, 107, 449–455.
76.
GowriP.M., TiwariA.K., AliA.Z., RaoJ.M. (2007) Inhibition of alpha-glucosidase and amylase by bartogenic acid isolated from Barringtonia racemosa Roxb. seeds. Phytotherapy Research, 21, 796–799.
77.
Atta-ur-Rahman ZareenS., ChoudharyM.I., ChoudharyM.I., AkhtarM.N., KhanS.N. (2008) alpha-Glucosidase inhibitory activity of triterpenoids from Cichorium intybus. Journal of Natural Products, 71, 910–913.
78.
DeutschländeraM.S., LallN., Van de VenterM., HusseinA.A. (2011) Hypoglycemic evaluation of a new triterpene and other compounds isolated from Euclea undulata Thunb. var. myrtina (Ebenaceae) root bark. Journal of Ethnopharmacology, 133, 1091–1095.
79.
LaiY.C., ChenC.K., TsaiS.F., LeeS.S. (2012) Triterpenes as α-glucosidase inhibitors from Fagus hayatae. Phytochemistry, 74, 206–211.
80.
UddinG., RaufA., Al-OthmanA.M., CollinaS., ArfanM., AliA., KhanI. (2012) Pistagremic acid, a glucosidase inhibitor from Pistacia integerrima. Fitoterapia, 83, 1648–1652.
81.
KwonO., EckP., ChenS., CorpeC.P., LeeJ.H., KruhlakM., LevineM. (2007) Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. Faseb Journal, 21, 366–377.
82.
YoshikawaM., MurakamiT., MatsudaH. (1997) Medicinal foodstuffs. X. Structures of new triterpene glycosides, gymnemosides-c, -d, -e, and -f, from the leaves of Gymnema sylvestre R. Br.: influence of gymnema glycosides on glucose uptake in rat small intestinal fragments. Chemical & Pharmaceutical Bulletin, 45, 2034–2038.
83.
KashiwagiA. (1995) Rationale and hurdles of inhibitors of hepatic gluconeogenesis in treatment of diabetes mellitus. Diabetes Research and Clinical Practice, 28, Suppl, S195–200.
84.
YamadaK., HosokawaM., FujimotoS., FujiwaraH., FujitaY., HaradaN., YamadaC., FukushimaM., UedaN., KanekoT., MatsuyamaF., YamadaY., SeinoY., InagakiN. (2008) Effect of corosolic acid on gluconeogenesis in rat liver. Diabetes Research and Clinical Practice, 80, 48–55.
85.
WamilM., SecklJ.R. (2007) Inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discovery Today, 12, 504–520.
86.
StulnigT.M., WaldhäuslW. (2004) 11β-Hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia, 47, 1–11.
VuorinenA., SeibertJ., PapageorgiouV.P., RollingerJ.M., OdermattA., SchusterD., AssimopoulouA.N. (2015) Pistacia lentiscus oleoresin: virtual screening and identification of masticadienonic and isomasticadienonic acids as inhibitors of 11β-hydroxysteroid dehydrogenase 1. Planta Medica, 81, 525–532.
89.
DeaconC.F., JohnsenA.H., HolstJ.J. (1995) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide which is a major endogenous metabolite in vivo. Journal of Clinical Endocrinology and Metabolism, 80, 952–957.
90.
LiS., CuiB., LiuQ., TangL., YangY., JinX., ShenZ. (2012) New triterpenoids from the leaves of Cyclocarya paliurus. Planta Medica, 78, 290–296.
91.
SaleemS., JafriL., ul HaqI., ChangL.C., CalderwoodD., GreenB.D., MirzaB. (2014) Plants Fagonia cretica L. and Hedera nepalensis K. Koch contain natural compounds with potent dipeptidyl peptidase-4 (DPP-4) inhibitory activity. Journal of Ethnopharmacology, 156, 26–32.
92.
HarveyA.L. (2008) Natural products in drug discovery. Drug Discovery Today, 13, 894–901.
93.
BaeE.A., ParkS.Y., KimD.H. (2000) Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biological & Pharmaceutical Bulletin, 23, 1481–1485.
94.
KimD.H., HongS.W., KimB.T., BaeE.A., ParkH.Y., HanM.J. (2000) Biotransformation of glycyrrhizin by human intestinal bacteria and its relation to biological activities. Archives of Pharmacal Research, 23, 172–177.
